GCP
WST icon

Garda Capital Partners’s West Pharmaceutical WST Stock Holding History

Garda Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,900
Closed -$635K – 512
2025
Q2 		$635K Hold
2,900
– – 0.02% 434
2025
Q1 		$649K Buy
+2,900
New +$799K 0.02% 499
2024
Q4 		– Sell
-2,500
Closed -$750K – 520
2024
Q3 		$750K Hold
2,500
– – 0.02% 433
2024
Q2 		$823K Buy
+2,500
New +$884K 0.03% 362

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Garda Capital Partners's WST Position: Q4 2024 in Review

Garda Capital Partners sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 1,554 shares — an estimated $489K sold.

Garda Capital Partners first reported a position in WST in Q2 2024 and held it in 2 quarters. The position peaked at $466K in Q3 2024. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Garda Capital Partners reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Garda Capital Partners sold 1,554 West Pharmaceutical shares in Q4 2024, an estimated $489K.
  • Garda Capital Partners first reported a position in West Pharmaceutical in Q2 2024 and held it in 2 quarters.
  • Garda Capital Partners's West Pharmaceutical position peaked at $466K in Q3 2024.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Garda Capital Partners's 13F filing for Q4 2024, filed 5 Feb 2025.